Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Chiao En Wu, Yi Hua Liao, Cheng Lin Wu, Ruoh Fang Yen, Chia Chi Lin, Muh Hwa Yang, Chueh Chuan Yen, Wu Chou Su, Chia Jui Yen, Yi Fang Chang, Ming Fang Wu, Youngsen Yang, Chen Yuan Lin, Wen Chi Yang, Hui Ching Wang, Cheng Yuan Li, Yin Yu Ho, Yao Yu Chang, Chieh Shan Wu, Hsiu Cheng HsuKuang Hua Chen, Yenlin Huang, Chih Jung Chen, Pei Ju Chuang, Yung Chi Lai, Yu Yi Huang, Neng Chuan Tseng, Yi Ting Huang, Chia Yu Chu, John Wen-Cheng Chang

研究成果: Article同行評審

2 引文 斯高帕斯(Scopus)


Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.

頁(從 - 到)7-15
期刊Journal of the Formosan Medical Association
出版狀態Published - 2024 1月

All Science Journal Classification (ASJC) codes

  • 一般醫學


深入研究「Clinical practice consensus for the diagnosis and management of melanoma in Taiwan」主題。共同形成了獨特的指紋。